Predicting progression in patients followed with active surveillance for low-risk prostate cancer.
Itay Aharon Sternberg
No relevant relationships to disclose
Changhong Yu
No relevant relationships to disclose
Gal Elimelech Keren Paz
No relevant relationships to disclose
Philip H. Kim
No relevant relationships to disclose
Melanie Bernstein
No relevant relationships to disclose
Paul Lakin
No relevant relationships to disclose
Michael W. Kattan
No relevant relationships to disclose
Behdar Ehdaie
No relevant relationships to disclose
Vincent Paul Laudone
No relevant relationships to disclose
Peter T. Scardino
No relevant relationships to disclose
James Andrew Eastham
No relevant relationships to disclose
Karim A. Touijer
No relevant relationships to disclose